Product Summary
Cagrilintide Peptide Powder(CAS 1415456-99-3)Cagrilintide(also known as AM-833)is a long‑acting acylated amylin analogue, designed as agonist of amylin receptors (AMYR) and calcitonin receptors (CTR). It is a 37‑amino‑acid cyclic peptide with a disulfide bond and an N‑terminal fatty acid chain, ...
GMP factory supply cagrilintide peptide powder cas 1415456-99-3 purity 99%
Basic Properties
Trading Properties
GMP cagrilintide peptide powder
,99% pure cagrilintide peptide
,cagrilintide peptide powder cas 1415456-99-3
Cagrilintide Peptide Powder(CAS 1415456-99-3)
Cagrilintide(also known as AM-833)is a long‑acting acylated amylin analogue, designed as agonist of amylin receptors (AMYR) and calcitonin receptors (CTR). It is a 37‑amino‑acid cyclic peptide with a disulfide bond and an N‑terminal fatty acid chain, engineered for once‑weekly dosing in obesity and type 2 diabetes research.
Product Name: Cagrilintide
CAS Number: 1415456-99-3
Molecular Formula: C₁₈₈H₂₈₉N₅₁O₅₇S₂
Molecular Weight: ~4,030 Da
Sequence: Pyr‑Lys‑Cys‑Asn‑Thr‑Ala‑Thr‑Cys‑Ala‑Thr‑Gln‑Arg‑Leu‑Ala‑Glu‑Phe‑Leu‑Arg‑His‑Ser‑Ser‑Asn‑Asn‑Phe‑Gly‑Pro‑Ile‑Leu‑Pro‑Pro‑Thr‑Asn‑Val‑Gly‑Ser‑Asn‑Thr‑Pro‑NH₂(Disulfide bridge: Cys3–Cys8)
Appearance: White to off‑white lyophilized powder
Purity: ≥98%(HPLC);available up to 99.9%
Solubility: Soluble in water and aqueous buffers
Amylin & Calcitonin Receptor Co‑agonist: Activates AMYR/CTR in the brainstem, slowing gastric emptying, reducing food intake, and decreasing body weight.
Long Half‑Life: Fatty acid acylation enables albumin binding, extending half‑life for once‑weekly administration.
Complementary to GLP‑1: Often studied in combination with semaglutide(CagriSema)for enhanced weight loss and glycemic control.
Applications
Obesity Research: Induces significant weight reduction in preclinical models;supports anti‑obesity development.
Type 2 Diabetes: Improves glycemic control by slowing gastric emptying and reducing postprandial glucose excursions.
Metabolic Disorder Studies: Used in research on insulin resistance, fatty liver disease, and appetite regulation.
Pharmaceutical Development: Key component in CagriSema(cagrilintide/semaglutide)combination therapy trials.
Quality Assurance
High Purity: ≥98% HPLC;verified by MALDI‑TOF/MS and amino acid analysis.
GMP‑Compatible Production: Manufactured under strict quality control for research and clinical trial use.
Documentation: Supplied with COA,HPLC,MS,SDS.
Our Advantages
Custom Packaging: 1 mg,5 mg,10 mg,50 mg,100 mg and bulk quantities.
Global Shipping: Fast cold‑chain delivery to labs and pharmaceutical companies worldwide.
Technical Support: Comprehensive product data and application protocols provided.
Order Information
Product: Cagrilintide Peptide Powder
CAS: 1415456-99-3
Purity: ≥98%(HPLC)
Form: Lyophilized Powder

-
Aso good quality, nice
Please use our online inquiry contact form below if you have any questions, our team will get back to you as soon as possible.